KORU Medical Systems, Inc. (KRMD) DCF Valuation
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
KORU Medical Systems, Inc. (KRMD) Bundle
Evaluate KORU Medical Systems, Inc.'s financial outlook like an expert! This (KRMD) DCF Calculator provides you with pre-filled financials and the complete flexibility to modify revenue growth, WACC, margins, and other essential assumptions to align with your projections.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 23.2 | 24.2 | 23.5 | 27.9 | 28.5 | 30.1 | 31.8 | 33.6 | 35.5 | 37.5 |
Revenue Growth, % | 0 | 4.38 | -2.84 | 18.76 | 2.23 | 5.63 | 5.63 | 5.63 | 5.63 | 5.63 |
EBITDA | 4.3 | 1.6 | -6.6 | -10.2 | -9.4 | -4.3 | -4.6 | -4.8 | -5.1 | -5.4 |
EBITDA, % | 18.74 | 6.66 | -27.95 | -36.54 | -32.96 | -14.41 | -14.41 | -14.41 | -14.41 | -14.41 |
Depreciation | .3 | .4 | .5 | .6 | .9 | .6 | .7 | .7 | .7 | .8 |
Depreciation, % | 1.47 | 1.73 | 1.97 | 2.1 | 3.05 | 2.07 | 2.07 | 2.07 | 2.07 | 2.07 |
EBIT | 4.0 | 1.2 | -7.0 | -10.8 | -10.3 | -5.0 | -5.2 | -5.5 | -5.8 | -6.2 |
EBIT, % | 17.28 | 4.93 | -29.93 | -38.65 | -36.01 | -16.48 | -16.48 | -16.48 | -16.48 | -16.48 |
Total Cash | 5.9 | 27.3 | 25.3 | 17.4 | 11.5 | 19.8 | 20.9 | 22.0 | 23.3 | 24.6 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 3.2 | 2.6 | 4.3 | 4.5 | 4.1 | 4.4 | 4.7 | 4.9 | 5.2 | 5.5 |
Account Receivables, % | 13.96 | 10.64 | 18.35 | 16.24 | 14.29 | 14.7 | 14.7 | 14.7 | 14.7 | 14.7 |
Inventories | 2.4 | 6.8 | 6.1 | 6.4 | 3.5 | 6.0 | 6.3 | 6.7 | 7.1 | 7.5 |
Inventories, % | 10.31 | 28.25 | 26 | 22.96 | 12.21 | 19.94 | 19.94 | 19.94 | 19.94 | 19.94 |
Accounts Payable | .6 | .6 | 1.2 | 2.4 | 1.0 | 1.3 | 1.4 | 1.5 | 1.6 | 1.7 |
Accounts Payable, % | 2.47 | 2.58 | 5.23 | 8.57 | 3.42 | 4.46 | 4.46 | 4.46 | 4.46 | 4.46 |
Capital Expenditure | -.4 | -1.1 | -.4 | -2.8 | -.8 | -1.2 | -1.3 | -1.4 | -1.5 | -1.6 |
Capital Expenditure, % | -1.84 | -4.39 | -1.6 | -10.04 | -2.86 | -4.14 | -4.14 | -4.14 | -4.14 | -4.14 |
Tax Rate, % | -40.59 | -40.59 | -40.59 | -40.59 | -40.59 | -40.59 | -40.59 | -40.59 | -40.59 | -40.59 |
EBITAT | 3.2 | 1.2 | -5.0 | -8.7 | -14.4 | -4.3 | -4.5 | -4.8 | -5.1 | -5.4 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -1.9 | -3.2 | -5.4 | -10.3 | -12.4 | -7.4 | -5.7 | -6.0 | -6.4 | -6.7 |
WACC, % | 6.32 | 6.34 | 6.31 | 6.32 | 6.34 | 6.32 | 6.32 | 6.32 | 6.32 | 6.32 |
PV UFCF | ||||||||||
SUM PV UFCF | -27.1 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -7 | |||||||||
Terminal Value | -159 | |||||||||
Present Terminal Value | -117 | |||||||||
Enterprise Value | -144 | |||||||||
Net Debt | -7 | |||||||||
Equity Value | -137 | |||||||||
Diluted Shares Outstanding, MM | 46 | |||||||||
Equity Value Per Share | -3.01 |
What You Will Receive
- Flexible Forecast Inputs: Modify key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: KORU Medical Systems, Inc.'s (KRMD) financial data pre-loaded to facilitate your analysis.
- Automated DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A refined Excel model tailored to meet your valuation requirements.
- Designed for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Comprehensive DCF Calculator: Features both unlevered and levered DCF valuation models tailored for KORU Medical Systems, Inc. (KRMD).
- WACC Calculator: A pre-configured Weighted Average Cost of Capital tool with adjustable parameters.
- Customizable Forecast Assumptions: Easily update growth projections, capital expenditures, and discount rates.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to KORU Medical Systems, Inc. (KRMD).
- Interactive Dashboard and Charts: Visual representations that encapsulate essential valuation metrics for straightforward analysis.
How It Works
- Download the Template: Gain immediate access to the Excel-based KORU Medical Systems DCF Calculator for (KRMD).
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates KORU Medical Systems' intrinsic value.
- Test Scenarios: Experiment with different assumptions to assess potential valuation shifts.
- Analyze and Decide: Utilize the results to inform your investment or financial decisions.
Why Choose This Calculator for KORU Medical Systems, Inc. (KRMD)?
- Accurate Data: Utilize real KORU Medical financials for dependable valuation outcomes.
- Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
- Time-Saving: Pre-configured calculations save you the hassle of starting from the ground up.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the medical sector.
- User-Friendly: Clear layout and guided instructions make it accessible for all users.
Who Should Use KORU Medical Systems, Inc. (KRMD)?
- Healthcare Providers: Enhance patient care with innovative medical delivery systems.
- Investors: Analyze growth potential with cutting-edge medical technology insights.
- Medical Professionals: Streamline procedures using advanced and reliable medical devices.
- Researchers: Explore new applications and improvements in medical delivery systems.
- Educators and Students: Utilize KORU's solutions as case studies in healthcare technology courses.
What the Template Contains
- Preloaded KRMD Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.